Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioventix Regulatory News (BVXP)

Share Price Information for Bioventix (BVXP)

Share Price is delayed by 15 minutes
Get Live Data
1,675.00    20.00 (1.21%)
Bid:
1,650.00
Ask:
1,700.00
Spread: 50.00 (3.03%)
Market Cap: £87.52m
BVXP Live PriceLast checked at - London Stock Exchange

Intraday Bioventix Share Chart

Holding(s) in Company

7 Nov 2023 12:07

RNS Number : 6730S
BioVentix PLC
07 November 2023
 

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Bioventix plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Gresham House Asset Management Limited

City and country of registered office (if applicable)

London, UK

4. Full name of shareholder(s) (if different from 3.) v

Name

Baronsmead Venture Trust plc

Baronsmead Second Venture Trust plc

WS Gresham House UK Multi Cap Income Fund

City and country of registered office (if applicable)

London, UK

5. Date on which the threshold was crossed or reached vi:

01/11/2023

6. Date on which issuer notified (DD/MM/YYYY):

06/11/2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

11.07%

11.07%

577,782

Position of previous notification (if

applicable)

5.02%

N/A

5.02%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

GB00B4QVDF07

577,782

11.07%

SUBTOTAL 8. A

577,782

11.07%

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

X

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Baronsmead Venture Trust plc

Below 3%

Below 3%

Baronsmead Second Venture Trust plc

Below 3%

Below 3%

WS Gresham House UK Multi Cap Income Fund

6.97%

6.97%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

Gresham House Asset Management Limited

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional information xvi

 

Place of completion

Gresham House Asset Management Limited, London

Date of completion

06/11/2023

 

 

 

 

Notes

 

i Please note this form should be read jointly with the applicable Disclosure Guidance and Transparency Rules Chapter 5 (DTR5) available on the following link: https://www.handbook.fca.org.uk/handbook/DTR/5/?view=chapter

 

ii Full name of the legal entity and further specification of the issuer or underlying issuer, provided it is reliable and accurate (e.g. address, LEI, domestic number identity). Indicate in the relevant section whether the issuer is a non UK issuer.

 

iii Other reason for the notification could be voluntary notifications, changes of attribution of the nature of the holding (e.g. expiring of financial instruments) or acting in concert.

 

iv This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in DTR5.2.1 (b) to (h); (c) all parties to the agreement referred to in DTR5.2.1 (a) or (d) the holder of financial instruments referred to in DTR5.3.1.

 

As the disclosure of cases of acting in concert may vary due to the specific circumstances (e.g. same or different total positions of the parties, entering or exiting of acting in concert by a single party) the standard form does not provide for a specific method how to notify cases of acting in concert.

 

In relation to the transactions referred to in DTR5.2.1 (b) to (h), the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in DTR5.2.1 (b), the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (c), the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in DTR5.2.1 (d), the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in DTR5.2.1 (e), the controlling natural person or legal entity and, provided it has a notification duty at an individual level under DTR 5.1, under DTR5.2.1 (a) to (d) or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in DTR5.2.1 (f), the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in DTR5.2.1 (g), the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in DTR5.2.1 (h), the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion (e.g. management companies).

 

v Applicable in the cases provided for in DTR5.2.1 (b) to (h). This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to DTR5.2 unless the percentage of voting rights held by the shareholder is lower than the lowest notifiable threshold for the disclosure of voting rights holdings in accordance with national practices (e.g. identification of funds managed by management companies).

 

vi The date on which threshold is crossed or reached should be the date on which the acquisition or disposal took place or the other reason triggered the notification obligation. For passive crossings, the date when the corporate event took effect.

 

vii The total number of voting rights held in the issuer shall be composed of all the shares, including depository receipts representing shares, to which voting rights are attached even if the exercise thereof is suspended.

 

viii If the holding has fallen below the lowest applicable threshold, please note that it might not be necessary to disclose the extent of the holding, only that the new holding is below that threshold.

 

ix In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

x Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

xi If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

xii In case of cash settled instruments the number and percentages of voting rights is to be presented on a delta-adjusted basis (DTR 5.3.3.A).

 

xiii If the person subject to the notification obligation is either controlled and/or does control another undertaking then the second option applies.

 

xiv The full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity has to be presented also in the cases, in which only on subsidiary level a threshold is crossed or reached and the subsidiary undertaking discloses the notification as only in this way will the markets get always the full picture of the group holdings. In case of multiple chains through which the voting rights and/or financial instruments are effectively held the chains have to be presented chain by chain by numbering each chain accordingly. Please see the below example: 

Name of ultimate controlling person A (chain 1)

Name of controlled undertaking B

Name of controlled undertaking C

Name of ultimate controlling person A (chain 2)

Name of controlled undertaking B

Name of controlled undertaking D

Name of ultimate controlling person A (chain3)

Name of controlled undertaking E

Name of controlled undertaking F

 

xv The names of controlled undertakings through which the voting rights and/or financial instruments are effectively held have to be presented irrespectively whether the controlled undertakings cross or reach the lowest applicable threshold themselves.

 

xvi Example: Correction of a previous notification.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFIFLLLDIIV
Date   Source Headline
18th May 20268:45 amRNSHolding(s) in Company
28th Apr 20263:45 pmRNSDirector Dealing
20th Apr 202611:54 amRNSShare Options Awarded
13th Apr 20267:00 amRNSDirector Dealing
8th Apr 20264:20 pmRNSDirector Dealing
30th Mar 20267:00 amRNSInterim Results
24th Feb 20267:00 amRNSAppointment of Non-Executive Director
4th Dec 20253:59 pmRNSResult of AGM
26th Nov 20258:50 amRNSDirector Dealing
11th Nov 20257:00 amRNSPosting of Annual Report and Notice of AGM
4th Nov 20254:12 pmRNSDirector Dealing
30th Oct 20257:00 amRNSDirector Dealing
27th Oct 20253:53 pmRNSDirector Dealing
27th Oct 20257:00 amRNSResults for the year ended 30 June 2025
13th Aug 20252:19 pmRNSHolding(s) in Company
28th Apr 20255:13 pmRNSDirector Dealing
11th Apr 20257:00 amRNSExercise of Options and Issue of Equity
31st Mar 20257:00 amRNSInterim Results
24th Dec 20249:14 amRNSDirector Dealing
6th Dec 20247:00 amRNSResult of AGM
4th Dec 20243:34 pmRNSHolding(s) in Company
22nd Nov 20243:56 pmRNSDirector/PDMR Shareholding
8th Nov 20247:57 amRNSNotice of AGM
31st Oct 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 20247:00 amRNSResults for the year ended 30 June 2024
25th Oct 202410:37 amRNSHolding(s) in Company
16th Oct 20241:51 pmRNSHolding(s) in Company
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 202411:05 amRNSHolding(s) in Company
25th Mar 20247:00 amRNSInterim Results
29th Jan 20243:15 pmRNSDirector/PDMR Shareholding
7th Dec 20233:26 pmRNSResult of AGM
28th Nov 20233:26 pmRNSDirector/PDMR Shareholding
16th Nov 202312:40 pmRNSHolding(s) in Company
10th Nov 20234:23 pmRNSPosting of Annual Report and Notice of AGM
7th Nov 202312:07 pmRNSHolding(s) in Company
1st Nov 20234:07 pmRNSHolding(s) in Company
30th Oct 20237:00 amRNSResults for the year ended 30 June 2023
25th Sep 20234:28 pmRNSHolding(s) in Company
19th Sep 20232:29 pmRNSHolding(s) in Company
24th Jul 20237:00 amRNSHolding(s) in Company
6th Jul 20232:48 pmRNSHolding(s) in Company
30th May 20237:00 amRNSBoard Appointment
19th May 20237:00 amRNSDirector/PDMR Shareholdings and Issue of Equity
25th Apr 202310:35 amRNSDirector/PDMR Shareholding
11th Apr 20232:45 pmRNSHolding(s) in Company
31st Mar 20232:45 pmRNSDirector/PDMR Shareholding
27th Mar 20237:00 amRNSInterim Statement
8th Mar 20235:50 pmRNSHolding(s) in Company
31st Jan 20235:03 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.